Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Robert I. Haddad(Georgetown University), Susan Darlow(National Comprehensive Cancer Network), Dominick Lamonica(Dana-Farber Brigham Cancer Center), Rebecca S. Sippel(University of Wisconsin–Madison), Andrei Iagaru(Stanford University), Erik Blomain(Cancer Institute (WIA)), Victor Bernet, Carly J. Cassara(National Comprehensive Cancer Network), Theresa Guo(National Foundation for Cancer Research), Jennifer A. Sipos(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Cord Sturgeon(Northwestern University), Lori J. Wirth(Massachusetts General Hospital), Whitney Goldner(University of Nebraska Medical Center), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Megan R. Haymart(University of Michigan), Paxton V. Dickson(University of Tennessee Health Science Center), Shelby Holt(Southwestern Medical Center), Michael W. Yeh(University of California, Los Angeles), Naifa L. Busaidy(The University of Texas MD Anderson Cancer Center), Mara Y. Roth(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Douglas W. Ball(Johns Hopkins University), Bryan McIver, John A. Ridge(Fox Chase Cancer Center), Thomas N. Wang(University of Colorado Cancer Center), Richard J. Wong(Memorial Sloan Kettering Cancer Center), Quan‐Yang Duh(University of California, San Francisco), Rod Rezaee(Cleveland Clinic), Randall P. Scheri(Duke University), Michael J. Campbell(UC Davis Comprehensive Cancer Center), Christopher D. Raeburn(University of Colorado Anschutz Medical Campus), Hormoz Ehya(Fox Chase Cancer Center), Susan J. Mandel(University of Pennsylvania), Jason P. Hunt(University of Utah), Fouad Kandeel(City of Hope), Lindsay Bischoff(Breast Cancer Research Foundation), Stephanie Markovina(Washington University in St. Louis)
Cited by 507
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k